瑞雷治疗 RLAY
$18.60 +$1.60 (+9.41%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $18.88 +1.51%
开盘$17.14
昨收$17.00
当日区间$16.66 – $18.72
成交量3.20M
市值$4.11B
市盈率（TTM）–
股息率–
RLAY 相关新闻
匹配 Relay Therapeutics 或代码 RLAY 的头条新闻，按最新排序。
- JonesTrading Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Maintains Target Price $20
- CCORF Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Maintains Target Price $29
- Barclays Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Raises Target Price to $30 正面
- TD Cowen Maintains Relay Therapeutics(RLAY.US) With Buy Rating
- J.P. Morgan Maintains Relay Therapeutics(RLAY.US) With Buy Rating
- H.C. Wainwright Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Maintains Target Price $29
- H.C. Wainwright Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Raises Target Price to $29 正面
- J.P. Morgan Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Announces Target Price $31
- Citizens JMP Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Raises Target Price to $26 正面
- Goldman Sachs Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Raises Target Price to $31 正面
- CCORF Initiates Relay Therapeutics(RLAY.US) With Buy Rating, Announces Target Price $29
- Goldman Sachs Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Maintains Target Price $22
- Analysts Are Bullish on These Healthcare Stocks: BrightSpring Health Services, Inc. (BTSG), Relay Therapeutics (RLAY) 正面
- Oppenheimer Maintains Relay Therapeutics(RLAY.US) With Buy Rating, Maintains Target Price $18
- A Quick Look at Today's Ratings for Relay Therapeutics(RLAY.US), With a Forecast Between $18 to $21
暂无评论——快来第一个聊聊 RLAY。
登录后参与讨论。